מה יתרונם של סטארטאפים מקומיים מול מקביליהם הזרים? אילו תעשיות צומחות בלב התקופה הנוכחית ואילו הזדמנויות חבויות בסקטורים החווים את הקשיים הרבים מכל?
מדוע יתכן וחברות הזנק ישראליות שנחשבות תמיד
Materiality Provisions in Purchase Agreements
It is important for parties to a transaction who come from other less-litigious business environments to know that U.S. buyers and sellers operate in an environment where litigation is far
Continue Reading Materiality Provisions in Purchase Agreements
GT Tel Aviv Office and Managing Shareholder Recognized by Chambers and Partners
The Greenberg Traurig Tel Aviv office is proud to once again be acknowledged by Chambers Global as a leading firm under the Israel-Corporate/M&A (Desk based Abroad) category. Apart from the
Continue Reading GT Tel Aviv Office and Managing Shareholder Recognized by Chambers and Partners
A Guide to Understanding Anti-Assignment Clauses
Introduction
With the increasing trend of globalization in the business world, Israeli companies and investors are commonly entering into agreements with U.S.-based entities. One of the most frequently found clauses
Continue Reading A Guide to Understanding Anti-Assignment Clauses
Greenberg Traurig Tel Aviv and Shanghai Offices Sponsor the First Ever China-Israel Technology, Innovation and Investment Summit
Earlier this month, the first ever China-Israel Technology, Innovation and Investment Summit, jointly sponsored by the Greenberg Traurig Tel Aviv and Shanghai offices, took place in Beijing. The 3-day
Continue Reading Greenberg Traurig Tel Aviv and Shanghai Offices Sponsor the First Ever China-Israel Technology, Innovation and Investment Summit
Attorney Spotlight: Ephraim Schmeidler on Growing Cross-Border Work for Israeli Businesses
Name: Ephraim Schmeidler
Member of GT since: 2012
Describe your involvement with the Greenberg Traurig Israel Practice Group: I received my legal training in
Continue Reading Attorney Spotlight: Ephraim Schmeidler on Growing Cross-Border Work for Israeli Businesses
Teva buys Mexico’s Rimsa for US$2.3 billion
In
a recent deal that has been reported in press outlets around the globe, Israeli pharmaceuticals company Teva has purchased Mexican counterpart Rimsa for US$2.3 billion. Continue Reading.
Continue Reading Teva buys Mexico’s Rimsa for US$2.3 billion
Greenberg Traurig to Host Webinar: ‘Doing M&A Deals in Israel’
Greenberg Traurig’s Tel Aviv office will be hosting a webinar “Doing M&A Deals in Israel” to be presented by Shareholder Joey T. Shabot. The discussion will review common transaction
Continue Reading Greenberg Traurig to Host Webinar: ‘Doing M&A Deals in Israel’
Israeli Executives Learn M&A Negotiation Techniques from Greenberg Traurig’s David Gitlin
On March 2, 2015, David Gitlin, a Corporate & Securities shareholder in Greenberg Traurig’s Philadelphia office and a member of the firm’s Israel Practice, presented a guest lecture
Continue Reading Israeli Executives Learn M&A Negotiation Techniques from Greenberg Traurig’s David Gitlin